Business Segments Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 24-08-13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 24-08-07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Developing Therapies | 192M | 153M | 129M | 119M | 118M | |||||
Total Assets | 800M | 633M | 455M | 396M | 109M | |||||
Interest Expense | -21.87M | -30.57M | -30.04M | -30.2M | -31.53M | |||||
Income Tax Expense | -1.28M | -8.07M | -5.12M | 30.67M | -43.17M | |||||
CAPEX | -90.43M | -4.39M | -191K | -136K | -264K | |||||
EBT | -274M | -108M | -109M | -35.25M | -296M | |||||
D&A | 33.97M | 40.9M | 33.65M | 32.71M | 31.67M | |||||
Operating Income | -312M | -78.08M | -79.04M | -35.34M | -265M | |||||
Net Income | -273M | -99.59M | -104M | -65.92M | -253M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 192M | 153M | 129M | 119M | 118M | |||||
Total Assets | 800M | 633M | 455M | 396M | 109M | |||||
Interest Expense | -21.87M | -30.57M | -30.04M | -30.2M | -31.53M | |||||
Income Tax Expense | -1.28M | -8.07M | -5.12M | 30.67M | -43.17M | |||||
D&A | 33.97M | 40.9M | 33.65M | 32.71M | 31.67M | |||||
CAPEX | -90.43M | -4.39M | -191K | -136K | -264K | |||||
Net Income | -273M | -99.59M | -104M | -65.92M | -253M | |||||
EBT | -274M | -108M | -109M | -35.25M | -296M | |||||
Operating Income | -312M | -78.08M | -79.04M | -35.34M | -265M |
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
- Financials Acorda Therapeutics
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
